Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
Saurabh Chhabra(Medical College of Wisconsin), Wael Saber(Medical College of Wisconsin), Olle Ringdén(Karolinska Institutet), Melhem Solh(Johns Hopkins Hospital), Sunita Nathan(Rush University Medical Center), Siddhartha Ganguly(University of Kansas Medical Center), Ronald Sobecks(Cleveland Clinic), Attaphol Pawarode(University of Michigan), Robert K. Stuart(Memorial Sloan Kettering Cancer Center), Andrew Daly, Edward A. Copelan(Levine Cancer Institute), Gerhard Hildebrandt(University of Missouri Health System), Yoshihiro Inamoto, Zhen‐Huan Hu(Medical College of Wisconsin), Harry C. Schouten, Zachariah DeFilipp(Harvard University), Jan Černý(Worcester Memorial Hospital), Hillard M. Lazarus(University Hospitals of Cleveland), Ann E. Woolfrey(University of Washington), Betty K. Hamilton(Cleveland Clinic), Sandeep Jain(Tata Memorial Hospital), Amer Assal(Columbia University Irving Medical Center), Sachiko Seo(National Cancer Center Hospital East), Abraham S. Kanate(HonorHealth), Uday Popat(The University of Texas MD Anderson Cancer Center), Jacob M. Rowe(Technion – Israel Institute of Technology), Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Celalettin Üstün(Rush University Medical Center), Richard F. Olsson(AstraZeneca (Netherlands)), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mark R. Litzow(Mayo Clinic in Arizona), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Nirav N. Shah(Medical College of Wisconsin), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), H. Jean Khoury(Emory University), Matt Kalaycio(Georgetown University), Jean A. Yared(University of Maryland, Baltimore), Jack W. Hsu(University of Florida Health), Kwang Woo Ahn(Medical College of Wisconsin)
Cited by 44
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k